Johnson & Johnson(Search results - 9)
World NewsSep 21, 2021, 5:49 PM IST
J&J announces second shot of COVID vaccine increases effectiveness to 94% in moderate, severe cases
The statistics will aid J&J's argument to US authorities for a booster injection, even as the firm emphasizes the durability of its single-shot vaccination as a weapon to combat the worldwide epidemic.
Top StoriesAug 20, 2021, 12:17 PM IST
Johnson & Johnson seeks permission to conduct COVID vaccine trials on adolescents in India
The J&J single-shot vaccine has shown 85% efficacy in protection against coronavirus in phase 3 clinical trials.
Top StoriesAug 7, 2021, 2:23 PM IST
Johnson & Johnson gets Emergency Use Approval for its single-dose COVID-19 vaccine in India
India has so far approved four vaccines - AstraZeneca's Covishield, Bharati Biotech's Covaxin, Russian Gamaleya Institute's Sputnik V and Moderna's vaccine.
United StatesAug 7, 2021, 11:48 AM IST
White House says 50 per cent of Americans fully vaccinated against COVID-19
As per the data, more than 165 million people have received either two Moderna or Pfizer doses or one Johnson & Johnson shot.
Top StoriesAug 6, 2021, 1:23 PM IST
Johnson & Johnson seeks DGCI nod for EUA of its single-dose COVID vaccine in India
Johnson & Johnson's vaccine is a single-dose jab, whereas the three vaccines cleared by India so far are of double doses.
Top StoriesAug 2, 2021, 5:03 PM IST
Johnson & Johnson withdraws proposal for speedy COVID vaccine approval in India
India had, in May, scrapped local trials for "well-established" foreign coronavirus vaccines as it tried to hasten vaccination rollouts to fight a second wave of infections.
CoronavirusJul 2, 2021, 3:08 PM IST
Johnson & Johnson’s single-shot COVID-19 vaccine shows strong activity against Delta variant
Data showed that the durability of the immune response lasted through at least eight months, the US-based healthcare company said, adding that its vaccine was 85% effective and could also help prevent hospitalization and death.
Top StoriesJun 28, 2021, 6:00 PM IST
Serum Institute urges govt to take up inclusion of Covishield in EU’s Vaccination Passport
Only four vaccines -- Comirnaty of Pfizer/BioNTech, Moderna, Vaxzervria by AstraZeneca-Oxford and Johnson & Johnson’s Janssen -- have been approved by the European Medicines Agency.
Coronavirus WorldApr 13, 2021, 10:01 PM IST
After 6.8 million doses, US FDA pauses use of Johnson & Johnson Covid-19 vaccine over 6 adverse cases
In a statement, US FDA said that even though the adverse effects seem very rare, it is reviewing the data along with the Centers for Disease Control and Prevention.